(NYSE: CBT) Cabot's forecast annual revenue growth rate of 1.65% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 2.53%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.57%.
Cabot's revenue in 2025 is $3,815,000,000.On average, 3 Wall Street analysts forecast CBT's revenue for 2025 to be $201,255,636,261, with the lowest CBT revenue forecast at $199,814,722,512, and the highest CBT revenue forecast at $202,971,825,560. On average, 3 Wall Street analysts forecast CBT's revenue for 2026 to be $207,348,515,281, with the lowest CBT revenue forecast at $206,246,508,617, and the highest CBT revenue forecast at $208,771,020,576.
In 2027, CBT is forecast to generate $213,142,230,324 in revenue, with the lowest revenue forecast at $210,828,404,716 and the highest revenue forecast at $215,198,550,391.